Natco Pharma has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand Name of NATGEN in the Indian Market.
NATCO estimates the current market size of CTPR containing products in India to be over INR 2000 crores.
Natco Pharma Limited is a vertically integrated and R&D-focused pharmaceutical company engaged in developing, manufacturing, and marketing of finished dosage formulations and active pharmaceutical ingredients. The company focuses primarily on niche therapeutic areas and complex products. Natco market and distribute its products in over 40 countries.
The company has seven manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.
